Extracellular vesicles

pathogenetic, diagnostic and therapeutic value in traumatic brain injury

Stefania Mondello, Eric P. Thelin, Gerry Shaw, Michel Salzet, Carmela Visalli, Dasa Cizkova, Firas Kobeissy, A. Büki

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Introduction: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Accurate classification according to injury-specific and patient-specific characteristics is critical to help informed clinical decision-making and to the pursuit of precision medicine in TBI. Reliable biomarker signatures for improved TBI diagnostics are required but still an unmet need. Areas covered: Extracellular vesicles (EVs) represent a new class of biomarker candidates in TBI. These nano-sized vesicles have key roles in cell signaling profoundly impacting pathogenic pathways, progression and long-term sequelae of TBI. As such EVs might provide novel neurobiological insights, enhance our understanding of the molecular mechanisms underlying TBI pathophysiology and recovery, and serve as biomarker signatures and therapeutic targets and delivery systems. Expert commentary: EVs are fast gaining momentum in TBI research, paving the way for new transformative diagnostic and treatment approaches. Their potential to sort out TBI variability and active involvement in the mechanisms underpinning different clinical phenotypes point out unique opportunities for improved classification, risk-stratification ad intervention, harboring promise of predictive, personalized, and even preemptive therapeutic strategies. Although a great deal of progress has been made, substantial efforts are still required to ensure the needed rigorous validation and reproducibility for clinical implementation of EVs.

Original languageEnglish
Pages (from-to)451-461
Number of pages11
JournalExpert Review of Proteomics
Volume15
Issue number5
DOIs
Publication statusPublished - May 4 2018

Fingerprint

Brain
Biomarkers
Therapeutics
Cell signaling
Precision Medicine
Extracellular Vesicles
Traumatic Brain Injury
Medicine
Cause of Death
Momentum
Decision making
Phenotype
Recovery
Wounds and Injuries
Research

Keywords

  • biomarker
  • exosomes
  • extracellular vesicles
  • microvesicles
  • TBI
  • Traumatic brain injury

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Extracellular vesicles : pathogenetic, diagnostic and therapeutic value in traumatic brain injury. / Mondello, Stefania; Thelin, Eric P.; Shaw, Gerry; Salzet, Michel; Visalli, Carmela; Cizkova, Dasa; Kobeissy, Firas; Büki, A.

In: Expert Review of Proteomics, Vol. 15, No. 5, 04.05.2018, p. 451-461.

Research output: Contribution to journalReview article

Mondello, S, Thelin, EP, Shaw, G, Salzet, M, Visalli, C, Cizkova, D, Kobeissy, F & Büki, A 2018, 'Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury', Expert Review of Proteomics, vol. 15, no. 5, pp. 451-461. https://doi.org/10.1080/14789450.2018.1464914
Mondello, Stefania ; Thelin, Eric P. ; Shaw, Gerry ; Salzet, Michel ; Visalli, Carmela ; Cizkova, Dasa ; Kobeissy, Firas ; Büki, A. / Extracellular vesicles : pathogenetic, diagnostic and therapeutic value in traumatic brain injury. In: Expert Review of Proteomics. 2018 ; Vol. 15, No. 5. pp. 451-461.
@article{f403090f5ee44ead95a322c6c23a8737,
title = "Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury",
abstract = "Introduction: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Accurate classification according to injury-specific and patient-specific characteristics is critical to help informed clinical decision-making and to the pursuit of precision medicine in TBI. Reliable biomarker signatures for improved TBI diagnostics are required but still an unmet need. Areas covered: Extracellular vesicles (EVs) represent a new class of biomarker candidates in TBI. These nano-sized vesicles have key roles in cell signaling profoundly impacting pathogenic pathways, progression and long-term sequelae of TBI. As such EVs might provide novel neurobiological insights, enhance our understanding of the molecular mechanisms underlying TBI pathophysiology and recovery, and serve as biomarker signatures and therapeutic targets and delivery systems. Expert commentary: EVs are fast gaining momentum in TBI research, paving the way for new transformative diagnostic and treatment approaches. Their potential to sort out TBI variability and active involvement in the mechanisms underpinning different clinical phenotypes point out unique opportunities for improved classification, risk-stratification ad intervention, harboring promise of predictive, personalized, and even preemptive therapeutic strategies. Although a great deal of progress has been made, substantial efforts are still required to ensure the needed rigorous validation and reproducibility for clinical implementation of EVs.",
keywords = "biomarker, exosomes, extracellular vesicles, microvesicles, TBI, Traumatic brain injury",
author = "Stefania Mondello and Thelin, {Eric P.} and Gerry Shaw and Michel Salzet and Carmela Visalli and Dasa Cizkova and Firas Kobeissy and A. B{\"u}ki",
year = "2018",
month = "5",
day = "4",
doi = "10.1080/14789450.2018.1464914",
language = "English",
volume = "15",
pages = "451--461",
journal = "Expert Review of Proteomics",
issn = "1478-9450",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Extracellular vesicles

T2 - pathogenetic, diagnostic and therapeutic value in traumatic brain injury

AU - Mondello, Stefania

AU - Thelin, Eric P.

AU - Shaw, Gerry

AU - Salzet, Michel

AU - Visalli, Carmela

AU - Cizkova, Dasa

AU - Kobeissy, Firas

AU - Büki, A.

PY - 2018/5/4

Y1 - 2018/5/4

N2 - Introduction: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Accurate classification according to injury-specific and patient-specific characteristics is critical to help informed clinical decision-making and to the pursuit of precision medicine in TBI. Reliable biomarker signatures for improved TBI diagnostics are required but still an unmet need. Areas covered: Extracellular vesicles (EVs) represent a new class of biomarker candidates in TBI. These nano-sized vesicles have key roles in cell signaling profoundly impacting pathogenic pathways, progression and long-term sequelae of TBI. As such EVs might provide novel neurobiological insights, enhance our understanding of the molecular mechanisms underlying TBI pathophysiology and recovery, and serve as biomarker signatures and therapeutic targets and delivery systems. Expert commentary: EVs are fast gaining momentum in TBI research, paving the way for new transformative diagnostic and treatment approaches. Their potential to sort out TBI variability and active involvement in the mechanisms underpinning different clinical phenotypes point out unique opportunities for improved classification, risk-stratification ad intervention, harboring promise of predictive, personalized, and even preemptive therapeutic strategies. Although a great deal of progress has been made, substantial efforts are still required to ensure the needed rigorous validation and reproducibility for clinical implementation of EVs.

AB - Introduction: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Accurate classification according to injury-specific and patient-specific characteristics is critical to help informed clinical decision-making and to the pursuit of precision medicine in TBI. Reliable biomarker signatures for improved TBI diagnostics are required but still an unmet need. Areas covered: Extracellular vesicles (EVs) represent a new class of biomarker candidates in TBI. These nano-sized vesicles have key roles in cell signaling profoundly impacting pathogenic pathways, progression and long-term sequelae of TBI. As such EVs might provide novel neurobiological insights, enhance our understanding of the molecular mechanisms underlying TBI pathophysiology and recovery, and serve as biomarker signatures and therapeutic targets and delivery systems. Expert commentary: EVs are fast gaining momentum in TBI research, paving the way for new transformative diagnostic and treatment approaches. Their potential to sort out TBI variability and active involvement in the mechanisms underpinning different clinical phenotypes point out unique opportunities for improved classification, risk-stratification ad intervention, harboring promise of predictive, personalized, and even preemptive therapeutic strategies. Although a great deal of progress has been made, substantial efforts are still required to ensure the needed rigorous validation and reproducibility for clinical implementation of EVs.

KW - biomarker

KW - exosomes

KW - extracellular vesicles

KW - microvesicles

KW - TBI

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85047508169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047508169&partnerID=8YFLogxK

U2 - 10.1080/14789450.2018.1464914

DO - 10.1080/14789450.2018.1464914

M3 - Review article

VL - 15

SP - 451

EP - 461

JO - Expert Review of Proteomics

JF - Expert Review of Proteomics

SN - 1478-9450

IS - 5

ER -